Robert W. Pangia is Director at BIOGEN INC. (BIIB). They have made 7 open-market trades across 4 companies since 2006, most recently 2020-06-03.
CIK 0001236188
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.0M since 2009, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BIIB | SELL | 2019-03-18 | 2019-03-19 | $328.55 | $4.0M | -27.0% | -30.1% | -28.4% |
| BIIB | SELL | 2018-01-09 | 2018-01-10 | $329.65 | $3.8M | +2.6% | -6.3% | -21.6% |
| BIIB | SELL | 2017-01-09 | 2017-01-10 | $295.39 | $3.2M | -7.1% | -8.9% | -9.3% |
| BIIB | SELL · 10b5-1 | 2015-03-10 | 2015-03-11 | $413.40 | $1.5M | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2014-04-01 | 2014-04-02 | $308.42 | $1.9M | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2014-01-06 | 2014-01-07 | $278.03 | $1.7M | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2013-05-28 | 2013-05-29 | $237.23 | $1.4M | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2013-02-06 | 2013-02-07 | $165.55 | $414K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2012-09-17 | 2012-09-18 | $155.00 | $775K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2012-09-06 | 2012-09-10 | $150.00 | $750K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2012-06-15 | 2012-06-18 | $140.00 | $700K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2012-06-04 | 2012-06-05 | $130.00 | $650K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2012-03-08 | 2012-03-12 | $120.00 | $900K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2011-05-26 | 2011-05-27 | $93.11 | $1.4M | -11.0% | -1.9% | -1.9% |
| MFE | SELL | 2010-11-09 | 2010-11-12 | $47.30 | $3.4M | N/A | N/A | N/A |
| BIIB | SELL · 10b5-1 | 2010-10-28 | 2010-10-29 | $64.00 | $960K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2009-12-24 | 2009-12-24 | $52.15 | $782K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2009-09-29 | 2009-09-30 | $52.00 | $780K | -11.0% | -1.9% | -1.9% |
| MFE | SELL | 2009-08-10 | 2009-08-12 | $42.75 | $1.1M | N/A | N/A | N/A |
| RGBO | BUY | 2009-01-16 | 2009-01-21 | $3.50 | $1.0M | N/A | N/A | N/A |
| BIIB | SELL · 10b5-1 | 2008-04-08 | 2008-04-10 | $64.75 | $712K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2008-04-08 | 2008-04-10 | $64.31 | $1.2M | -11.0% | -1.9% | -1.9% |
| ICOS | SELL | 2006-02-23 | 2006-02-23 | $24.51 | $436K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.